Free

Venture Philanthropy: Where Venture Capital Meets Social Impact

Actions and Detail Panel

Free

Event Information

Share this event

Date and time

Location

Location

Online event

Event description
In partnership with Women in Bio, BioPathways throughout 2021, will feature prominent female biotech founders, executives, and VCs.

About this event

Featuring Lindsay Androski, Founder, President & CEO of Roivant Social Ventures

Lindsay Androski is the founder, President and CEO of Roivant Social Ventures, a social impact organization that makes early stage investments & incubates biotechs focused on improving healthcare access and outcomes for underserved groups. Ms. Androski currently serves as President of Incubate, an advocacy organization that educates policymakers on the critical role of early-stage venture capital in biopharma. She is also a member of the MIT board of trustees and sits on the MIT Visiting Committees for Sponsored Research, the Department of Biology, and the Department of Humanities.

A noted expert in the creation, launch & scaling of biotechs, Ms. Androski joined the founding team at Roivant Sciences to build and lead the team responsible for the in-license or acquisition of more than 30 pharmaceutical drug candidates, resulting in the launch of 16 biotechs, three of which went public. To date, these efforts have led to four approved drugs now available to patients: Myfembree (heavy menstrual bleeding / uterine fibroids), Orgovyx (prostate cancer), Gemtesa (overactive bladder), and Rethymic (pediatric congenital athymia). In addition to her dealwork, Ms. Androski led hiring of CEOs and CMO’s, partnership efforts in Japan and China, alliance management across the Roivant family of companies, and the intellectual property team.

Ms. Androski previously joined the Department of Justice as one of the inaugural Assistant U.S. Attorneys in the newly-launched Cybercrime unit of the Eastern District of Virginia. As a federal prosecutor, Ms. Androski was involved in investigations and prosecutions of high-profile cybercrime and national security cases, including WikiLeaks/Assange/Manning, Edward Snowden, and MegaUpload/Kim Dotcom, was nominated several times for the highest award given by the Department of Justice, and received the highest awards given by Immigration and Customs Enforcement and Customs and Border Protection. She then took that expertise back to the private sector, launching and leading the Cyber and Data Security practice group at Irell & Manella LLP. She is admitted to practice law in the U.S. Supreme Court, the U.S. Courts of Appeals for the Federal and Fourth Circuits, and the courts of California, New York, and the District of Columbia.

Ms. Androski holds two BS degrees from the Massachusetts Institute of Technology (Biology and History), JD and MBA degrees from The University of Chicago, is a registered patent lawyer and a Chartered Financial Analyst. Her writings have been published in Nature Gene Therapy, the Harvard Journal of Law and Public Policy, the John Marshall Review of Intellectual Property Law, and the University of Chicago Legal Forum.


		Venture Philanthropy:  Where Venture Capital Meets Social Impact image

BioPathways is a monthly event series, featuring prominent bioentrepreneurs, biotech executives, and biotech investors in a fireside chat.

Share with friends

Date and time

Location

Online event

{ _('Organizer Image')}

Organizer SmartHealth Catalyzer

Organizer of Venture Philanthropy: Where Venture Capital Meets Social Impact

SmartHealth Catalyzer discovers and accelerates commercialization of biotechnology being developed at Midwest universities and research hospitals.

Save This Event

Event Saved